The role of allergy in severe asthma

Clinical and Experimental Allergy

Volumn 42, Issue 5, 2012, Pages 659-669

  Kennedy, J L ^a   Heymann, P W ^a   Platts Mills, T A E ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Acute asthma; Anti fungal; Classification; Fungal colonization; High titer IgE ab; Severe asthma

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ALLERGY; ALTERNARIA; ASPERGILLUS; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BACTERIAL COLONIZATION; DISEASE SEVERITY; HUMAN; IMMUNOTHERAPY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RHINOVIRUS INFECTION; SINUSITIS; VOCAL CORD DISORDER;

ALLERGENS; ANIMALS; ANTIGENS, FUNGAL; ANTIGENS, VIRAL; ASTHMA; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; INHALATION; OBESITY; RESPIRATORY SYSTEM; RHINOVIRUS; SEVERITY OF ILLNESS INDEX; SINUSITIS; VOCAL CORDS;

EID: 84859956113     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03944.x     Document Type: Review

References (83)

1. Tovey ER, Chapman MD, Platts-Mills TA. Mite faeces are a major source of house dust allergens. Nature 1981; 289:592-3.
2. Platts-Mills TAE, Mitchell EB, Tovey ER, Chapman MD, Wilkins SR. Airborne allergen exposure, allergen avoidance and bronchial hyperreactivity. In: Kay AB, Austen KF, Lichtenstein LM, eds. Asthma: physiology, immunopharmacology and treatment, Third International Symposium. London: Academic Press, 1984: 297-314.
3. Platts-Mills TAE, de Weck AL, Aalberse RC et al. Dust mite allergens and asthma - a worldwide problem. J Allergy Clin Immunol 1989; 83:416-27.
4. Altounyan RE. Review of clinical activity and mode of action of sodium cromoglycate. Clin Allergy 1980; 10(Suppl.):481-9.
5. Platts-Mills TA, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 1982; 2:675-8.
6. Kerrebijn K. Endogenous factors in childhood CNSLD: methodological aspects in population studies. the Netherlands: Royal Vangorcum Assesn, 1970:38-48.
7. Fitzpatrick AM, Gaston BM, Erzurum SC, Teague WG. Features of severe asthma in school-age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 2006; 118:1218-25.
8. National Heart, Lung, and Blood Institute. Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007;120: S94-138.
9. Reddel HK, Taylor DR, Bateman ED et al. An official American thoracic society/European respiratory society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
10. Duff AL, Pomeranz ES, Gelber LE et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993; 92:535-40.
11. Rakes GP, Arruda E, Ingram JM et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999; 159:785-90.
12. Heymann PW, Carper HT, Murphy DD et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 2004; 114:239-47.
13. Murray CS, Poletti G, Kebadze T et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006; 61:376-82.
14. Fairs A, Agbetile J, Hargadon B et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182:1362-8.
15. Beuther DA, Weiss ST, Sutherland ER. Obesity and asthma. Am J Respir Crit Care Med 2006; 174:112-9.
16. Shim YM, Herring RC, Burnett A et al. Cardiopulmonary exercise physiology among obese adolescents with or without a diagnosis of asthma. In press.
17. Platts-Mills TA, Vervloet D, Thomas WR, Aalberse RC, Chapman MD. Indoor allergens and asthma: report of the third international workshop. J Allergy Clin Immunol 1997; 100:S2-24.
18. Stevens DA, Schwartz HJ, Lee JY et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342:756-62.
19. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the fungal asthma sensitization trial (FAST) study. Am J Respir Crit Care Med 2009; 179:11-8.
20. Ward GWJr, Woodfolk JA, Hayden ML, Jackson S, Platts-Mills TA. Treatment of late-onset asthma with fluconazole. J Allergy Clin Immunol 1999; 104:541-6.
21. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010; 65:384-90.
22. Malerba M, Ragnoli B, Radaeli A, Tantucci C. Usefulness of exhaled nitric oxide and sputum eosinophils in the long-term control of eosinophilic asthma. Chest 2008; 134:733-9.
23. Wenzel SE, Schwartz LB, Langmack EL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160:1001-8.
24. Killian D, Cockcroft DW, Hargreave FE, Dolovich J. Factors in allergen-induced asthma: relevance of the intensity of the airways allergic reaction and non-specific bronchial reactivity. Clin Allergy 1976; 6:219-25.
25. Cockcroft DW, Hargreave FE, O'Byrne PM, Boulet LP. Understanding allergic asthma from allergen inhalation tests. Can Respir J 2007; 14:414-8.
26. Tovey ER, Chapman MD, Wells CW, Platts-Mills TA. The distribution of dust mite allergen in the houses of patients with asthma. Am Rev Respir Dis 1981; 124:630-5.
27. Svartengren M, Falk R, Linnman L, Philipson K, Camner P. Deposition of large particles in human lung. Exp Lung Res 1987; 12:75-88.
28. Bates DV, Fish BR, Hatch TF, Mercer TT, Morrow PE. Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics. Health Phys 1966; 12:173-207.
29. Yu M, Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006; 116:1633-41.
30. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101:1614-22.
31. Ayres JG, Mansur AH. Vocal cord dysfunction and severe asthma: considering the total airway. Am J Respir Crit Care Med 2011; 184:2-3.
32. Lemanske RFJr, Dick EC, Swenson CA, Vrtis RF, Busse WW. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989; 83:1-10.
33. Halperin SA, Eggleston PA, Beasley P et al. Exacerbations of asthma in adults during experimental rhinovirus infection. Am Rev Respir Dis 1985; 132:976-80.
34. Papadopoulos NG, Papi A, Psarras S, Johnston SL. Mechanisms of rhinovirus-induced asthma. Paediatr Respir Rev 2004; 5:255-60.
35. Zambrano JC, Carper HT, Rakes GP et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J Allergy Clin Immunol 2003; 111:1008-16.
36. Soto-Quiros ME, Avila L, Hunt J et al. Rhinovirus and assessments of airway inflammation among children treated for wheezing exacerbations in Costa Rica. Am J Respir Crit Care Med 2011; 183:A2761.
37. Summers QA, Higgins PG, Barrow IG, Tyrrell DA, Holgate ST. Bronchial reactivity to histamine and bradykinin is unchanged after rhinovirus infection in normal subjects. Eur Respir J 1992; 5:313-7.
38. de Kluijver J, Grunberg K, Sont JK et al. Rhinovirus infection in nonasthmatic subjects: effects on intrapulmonary airways. Eur Respir J 2002; 20:274-9.
39. Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest 1994; 94:2200-8.
40. Milgrom H, Fick RBJr, Su JQ et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 study group. N Engl J Med 1999; 341:1966-73.
41. Busse WW, Morgan WJ, Gergen PJ et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011; 364:1005-15.
42. Djukanovic R, Wilson SJ, Kraft M et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004; 170:583-93.
43. Eckman JA, Sterba PM, Kelly D et al. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. J Allergy Clin Immunol 2010; 125:889-95 e7.
44. Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011;2011: 843763.
45. Steel HC, Theron AJ, Tintinger GR, Anderson R. Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant-activated human neutrophils: a potential strategy to control neutrophil-mediated inflammation. J Antimicrob Chemother 2009; 64:1008-12.
46. Steel HC, Tintinger GR, Anderson R. Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure. Chem Biol Drug Des 2008; 72:225-8.
47. Parmar JS, Howell T, Kelly J, Bilton D. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax 2002; 57:749-50.
48. Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S. Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide. Eur Respir J 2002; 20:127-33.
49. Patterson K, Strek ME. Allergic bronchopulmonary aspergillosis. Proc Am Thorac Soc 2010; 7:237-44.
50. Proesmans M, Vermeulen F, Vreys M, De Boeck K. Use of nebulized amphotericin B in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Int J Pediatr 2010;2010: 376287.
51. Kuiper L, Ruijgrok EJ. A review on the clinical use of inhaled amphotericin B. J Aerosol Med Pulm Drug Deliv 2009; 22:213-27.
52. Gonzalez de Olano D, Gonzalez-Mancebo E, Gandolfo Cano M et al. Successful treatment of allergic bronchopulmonary candidiasis with a recombinant anti-immunoglobulin E antibody. J Investig Allergol Clin Immunol 2009; 19:416-7.
53. Halwig JM, Brueske DA, Greenberger PA, Dreisin RB, Sommers HM. Allergic bronchopulmonary curvulariosis. Am Rev Respir Dis 1985; 132:186-8.
54. O'Hollaren MT, Yunginger JW, Offord KP et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324:359-63.
55. O'Driscoll BR, Powell G, Chew F et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009; 39:1677-83.
56. Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997; 155:1356-61.
57. Wise F, Sulzberger MB. Urticaria and hay fever due to Trichophyton (Epidermophyton interdigital). JAMA 1930; 95:1504-8.
58. Platts-Mills TA, Fiocco GP, Hayden ML, Guerrant JL, Pollart SM, Wilkins SR. Serum IgE antibodies to Trichophyton in patients with urticaria, angioedema, asthma, and rhinitis: development of a radioallergosorbent test. J Allergy Clin Immunol 1987; 79:40-5.
59. Ward GW Jr, Karlsson G, Rose G, Platts-Mills TA. Trichophyton asthma: sensitisation of bronchi and upper airways to dermatophyte antigen. Lancet 1989; 1:859-62.
60. Matsuoka H, Niimi A, Matsumoto H et al. Specific IgE response to trichophyton and asthma severity. Chest 2009; 135:898-903.
61. Platts-Mills TA, Woodfolk JA. Trichophyton asthma. Chest 2009; 135:887-8.
62. Hope WW, Billaud EM, Lestner J, Denning DW. Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis 2008; 21:580-6.
63. Swineford O Jr. Asthma and hay fever. Springfield, IL, USA: Charles C Thomas, 1971.
64. Goshi K, Cluff LE, Norman PS. Studies on the pathogenesis of staphylococcal infection. V. Purification and characterization of staphylococcal alpha hemolysin. Bull Johns Hopkins Hosp 1963; 112:15-30.
65. Boles BR, Singh PK. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci USA 2008; 105:12503-8.
66. Denburg JA, Keith PK. Systemic aspects of chronic rhinosinusitis. Immunol Allergy Clin North Am 2004; 24:87-102.
67. Newman LJ, Platts-Mills TA, Phillips CD, Hazen KC, Gross CW. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 1994; 271:363-7.
68. Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010; 5:e8578.
69. Huang YJ, Nelson CE, Brodie EL et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127:372-81 e1-3.
70. Bisgaard H, Hermansen MN, Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-95.
71. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest 2007; 132:1962-6.
72. Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006; 354:1589-600.
73. Peters J, Singh H, Brooks EG et al. Persistence of CARDS toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 2011; 140:401-7.
74. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005; 172:1078-89.
75. Christopher KL, Wood RP 2nd, Eckert RC, Blager FB, Raney RA, Souhrada JF. Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983; 308:1566-70.
76. Peters EJ, Hatley TK, Crater SE, Phillips CD, Platts-Mills TA, Borish L. Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma. Ann Allergy Asthma Immunol 2003; 90:316-22.
77. Shore SA, Schwartzman IN, Mellema MS, Flynt L, Imrich A, Johnston RA. Effect of leptin on allergic airway responses in mice. J Allergy Clin Immunol 2005; 115:103-9.
78. Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol 2006; 118:389-95.
79. van Veen IH, Ten Brinke A, Sterk PJ, Rabe KF, Bel EH. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008; 63:570-4.
80. Rastogi D, Canfield SM, Andrade A et al. Obesity-associated asthma in children- a distinct entity. Chest 2011; Epub October 6, 2011.
81. Holguin F, Bleecker ER, Busse WW et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 2011; 127:1486-93 e2.
82. Haselden BM, Kay AB, Larche M. Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med 1999; 189:1885-94.
83. Reefer AJ, Carneiro RM, Custis NJ et al. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004; 172:2763-72.